← Back to Clinical Trials
Recruiting NCT05753683

NCT05753683 Gathering Online for Dialogue and Discussion to Enhance Social Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05753683
Status Recruiting
Phase
Sponsor RTI International
Condition Alcohol Misuse
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2025-04-07
Primary Completion 2027-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
mHealth-Women's CoOpVirtual Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2025-04-07 with a primary completion date of 2027-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with up to 500 young women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol. The expected outcomes are to: (1) determine the efficacy of the virtual group component in reducing alcohol use and sexual risk and increasing pre-exposure prophylaxis (PrEP) utilization; and (2) understand selected outcomes for implementation. Participants will be randomized to receive either the mHealth app or the mHealth app plus the group component, and followed up at 3- and 6-months post-enrollment.

Eligibility Criteria

Selected Inclusion Criteria: * identify as Black/African American * identify as female * be between 18 and 30 years old * recent substance use * HIV negative and not currently on PrEP * have an Android or iOS-based smartphone Selected Exclusion Criteria: * test positive for HIV * participated in the previous study activities of the current study or previous related studies

Contact & Investigator

Central Contact

Felicia A Browne, ScD, MPH

✉ fbrowne@rti.org

📞 9195416596

Principal Investigator

Felicia A Browne, ScD, MPH

PRINCIPAL INVESTIGATOR

RTI International

Frequently Asked Questions

Who can join the NCT05753683 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Alcohol Misuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05753683 currently recruiting?

Yes, NCT05753683 is actively recruiting participants. Contact the research team at fbrowne@rti.org for enrollment information.

Where is the NCT05753683 trial being conducted?

This trial is being conducted at Durham, United States.

Who is sponsoring the NCT05753683 clinical trial?

NCT05753683 is sponsored by RTI International. The principal investigator is Felicia A Browne, ScD, MPH at RTI International. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology